Most importantly, ANGPTL4 treatment could suppress HCC progression and metastasis through promotion of tumor apoptosis, inhibition of tumor motility and angiogenesis, and disruption of tumor-favorable microenvironment. The gene discussed is ANGPTL4; the disease is hepatocellular carcinoma.